CN1469746A - 逆转录病毒免疫疗法 - Google Patents
逆转录病毒免疫疗法 Download PDFInfo
- Publication number
- CN1469746A CN1469746A CNA018173802A CN01817380A CN1469746A CN 1469746 A CN1469746 A CN 1469746A CN A018173802 A CNA018173802 A CN A018173802A CN 01817380 A CN01817380 A CN 01817380A CN 1469746 A CN1469746 A CN 1469746A
- Authority
- CN
- China
- Prior art keywords
- cell
- medicine
- retrovirus
- virus
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (19)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ9488A AUPQ948800A0 (en) | 2000-08-18 | 2000-08-18 | A vaccine strategy |
AUPQ9488 | 2000-08-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1469746A true CN1469746A (zh) | 2004-01-21 |
CN100518739C CN100518739C (zh) | 2009-07-29 |
Family
ID=3823543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB018173802A Expired - Fee Related CN100518739C (zh) | 2000-08-18 | 2001-08-16 | 逆转录病毒免疫疗法 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1311267B1 (zh) |
JP (1) | JP2004506015A (zh) |
CN (1) | CN100518739C (zh) |
AU (2) | AUPQ948800A0 (zh) |
BR (1) | BR0113354A (zh) |
CA (1) | CA2431954A1 (zh) |
DK (1) | DK1311267T3 (zh) |
ES (1) | ES2389897T3 (zh) |
NZ (1) | NZ524280A (zh) |
PT (1) | PT1311267E (zh) |
WO (1) | WO2002013828A1 (zh) |
ZA (1) | ZA200301694B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104013959A (zh) * | 2014-05-21 | 2014-09-03 | 郭和友 | 逆转录抑制剂和免疫抗体细胞三联合疗法 |
CN108543225A (zh) * | 2018-04-03 | 2018-09-18 | 江西汉江科技发展有限公司 | 一种提高hiv患者cd4+t淋巴细胞并降低病载的近红外led理疗设备及其应用 |
CN111701016A (zh) * | 2020-06-28 | 2020-09-25 | 张全志 | 逆转录病毒原病毒序列在逆转录病毒疫苗设计中的应用 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPS065002A0 (en) | 2002-02-20 | 2002-03-14 | Immunaid Pty Ltd | Strategy for retroviral immunotherapy |
AUPS054702A0 (en) | 2002-02-14 | 2002-03-07 | Immunaid Pty Ltd | Cancer therapy |
AU2004283322B2 (en) * | 2003-10-24 | 2010-09-16 | Biotempus Pty Ltd | Method of therapy |
CN1898569A (zh) * | 2003-10-24 | 2007-01-17 | 伊缪因艾德有限公司 | 治疗方法 |
CA2579353C (en) * | 2004-09-08 | 2013-05-14 | Immunaid Pty Ltd | Therapeutic strategy for treating autoimmune and degenerative diseases |
WO2010135781A1 (en) | 2009-05-27 | 2010-12-02 | Immunaid Pty Ltd | Methods of treating diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4120296A1 (de) * | 1991-06-28 | 1992-03-19 | Regina Tilgner | Rein pflanzliches kombinationspraeparat - gegen aids |
-
2000
- 2000-08-18 AU AUPQ9488A patent/AUPQ948800A0/en not_active Abandoned
-
2001
- 2001-08-16 BR BR0113354-3A patent/BR0113354A/pt not_active IP Right Cessation
- 2001-08-16 EP EP01962453A patent/EP1311267B1/en not_active Expired - Lifetime
- 2001-08-16 WO PCT/AU2001/001019 patent/WO2002013828A1/en active IP Right Grant
- 2001-08-16 ZA ZA200301694A patent/ZA200301694B/en unknown
- 2001-08-16 DK DK01962453.5T patent/DK1311267T3/da active
- 2001-08-16 CA CA002431954A patent/CA2431954A1/en not_active Abandoned
- 2001-08-16 CN CNB018173802A patent/CN100518739C/zh not_active Expired - Fee Related
- 2001-08-16 PT PT01962453T patent/PT1311267E/pt unknown
- 2001-08-16 JP JP2002518971A patent/JP2004506015A/ja active Pending
- 2001-08-16 NZ NZ524280A patent/NZ524280A/en not_active IP Right Cessation
- 2001-08-16 AU AU2001283682A patent/AU2001283682A1/en not_active Abandoned
- 2001-08-16 ES ES01962453T patent/ES2389897T3/es not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104013959A (zh) * | 2014-05-21 | 2014-09-03 | 郭和友 | 逆转录抑制剂和免疫抗体细胞三联合疗法 |
CN108543225A (zh) * | 2018-04-03 | 2018-09-18 | 江西汉江科技发展有限公司 | 一种提高hiv患者cd4+t淋巴细胞并降低病载的近红外led理疗设备及其应用 |
CN111701016A (zh) * | 2020-06-28 | 2020-09-25 | 张全志 | 逆转录病毒原病毒序列在逆转录病毒疫苗设计中的应用 |
Also Published As
Publication number | Publication date |
---|---|
JP2004506015A (ja) | 2004-02-26 |
WO2002013828A1 (en) | 2002-02-21 |
ES2389897T3 (es) | 2012-11-02 |
DK1311267T3 (da) | 2012-09-10 |
PT1311267E (pt) | 2012-09-24 |
EP1311267A1 (en) | 2003-05-21 |
CN100518739C (zh) | 2009-07-29 |
AU2001283682A1 (en) | 2002-02-25 |
CA2431954A1 (en) | 2002-02-21 |
EP1311267A4 (en) | 2007-10-24 |
EP1311267B1 (en) | 2012-06-20 |
AUPQ948800A0 (en) | 2000-09-07 |
NZ524280A (en) | 2004-09-24 |
BR0113354A (pt) | 2003-07-08 |
ZA200301694B (en) | 2004-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kaneko et al. | Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein | |
JP2024010027A (ja) | B型肝炎ウイルスに対するワクチン | |
CN1646155A (zh) | 癌症疗法 | |
JPH06508153A (ja) | 免疫不全ウイルス用の遺伝子ワクチン | |
JP2019163286A (ja) | B型肝炎ウイルスコアタンパク質および表面抗原タンパク質をコードする核酸分子ならびにそれを含むワクチン | |
Flynn et al. | Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. | |
EP2978449A2 (en) | Compositions and methods for the treatment or prevention of human immunodeficiency virus infection | |
CN100518739C (zh) | 逆转录病毒免疫疗法 | |
Lori | DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS | |
CN105709221A (zh) | 用于预防和/或治疗人中的hiv疾病的药物组合物 | |
CN101057975B (zh) | 一种抗免疫耐受性和免疫缺陷性病毒的鸡尾酒疫苗及其应用 | |
US8465748B2 (en) | Vaccine compositions and methods containing an immunogen derived from equine arteritis virus | |
CN1646156A (zh) | 逆转录病毒免疫疗法的策略 | |
JP2000502900A (ja) | 組換えウイルス偽粒子ならびにそのワクチンおよび抗腫瘍性用途 | |
WO2013040766A1 (zh) | 可诱导针对hiv的广谱免疫应答的方法和疫苗 | |
JP2010029217A (ja) | Hiv特異的ctlを誘導し得るペプチド及び該ペプチドを含む抗aids予防・治療剤 | |
Ikawait | Role of cell-mediated immunity in bovine leukemia virus (BLV) infection in ruminants: its implication for the vaccination strategy against retroviruses | |
CN113185586B (zh) | SARS-CoV-2编码蛋白来源的T细胞表位多肽及其应用 | |
JP2002501369A (ja) | Fivワクチン | |
CN1092812A (zh) | 疫苗 | |
NZ741950B2 (en) | Vaccines against hepatitis b virus | |
Shen | Infection of newborn kittens with a feline immunodeficiency virus vif-deletion mutant | |
AU2003246604A1 (en) | Strategy for retroviral immunotherapy | |
EP0678033A1 (en) | Human aids vaccine from revertant cattle virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Vitoria, Australia Patentee after: Botaip Private Ltd. Address before: Vitoria, Australia Patentee before: Itzkam Katz Co.,Ltd. Address after: Vitoria, Australia Patentee after: Botep Co.,Ltd. Address before: Vitoria, Australia Patentee before: Immunization Aid Co.,Ltd. Address after: Vitoria, Australia Patentee after: Immunization Aid Co.,Ltd. Address before: Vitoria, Australia Patentee before: IMMUNAID Pty Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190225 Address after: Vitoria, Australia Patentee after: Itzkam Katz Co.,Ltd. Address before: Vitoria, Australia Patentee before: Botep Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090729 Termination date: 20190816 |
|
CF01 | Termination of patent right due to non-payment of annual fee |